An autoimmune disease is triggered by the immune system turning against the body it is designed to protect from invading pathogens. Pathologic immune cells attack the body’s own tissue, triggering a cascade of events that cause damage to the targeted tissue.
Using the full potential of gene editing, JURA Bio is creating a novel therapeutic platform of cell-based therapies against autoimmune diseases that are both curative and definitive. We have developed a disruptive treatment approach that is harnessing the body’s immune system to neutralize pathologic cells. We are developing therapeutic cells engineered to bind to and kill pathologic immune cells.